State Street’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Buy |
651,979
+88,575
| +16% | +$448K | ﹤0.01% | 3117 |
|
|
2025
Q1 | $3.18M | Buy |
563,404
+2,435
| +0.4% | +$13.8K | ﹤0.01% | 3062 |
|
|
2024
Q4 | $4.87M | Buy |
560,969
+68,964
| +14% | +$599K | ﹤0.01% | 2995 |
|
|
2024
Q3 | $3.41M | Buy |
492,005
+19,207
| +4% | +$133K | ﹤0.01% | 3127 |
|
|
2024
Q2 | $2.93M | Buy |
472,798
+445,198
| +1,613% | +$2.76M | ﹤0.01% | 3157 |
|
|
2024
Q1 | $43.6K | Hold |
27,600
| – | – | ﹤0.01% | 4185 |
|
|
2023
Q4 | $40.6K | Hold |
27,600
| – | – | ﹤0.01% | 4229 |
|
|
2023
Q3 | $25.7K | Hold |
27,600
| – | – | ﹤0.01% | 4416 |
|
|
2023
Q2 | $34.8K | Hold |
27,600
| – | – | ﹤0.01% | 4508 |
|
|
2023
Q1 | $37.8K | Hold |
27,600
| – | – | ﹤0.01% | 4573 |
|
|
2022
Q4 | $49.4K | Hold |
27,600
| – | – | ﹤0.01% | 4560 |
|
|
2022
Q3 | $87K | Hold |
27,600
| – | – | ﹤0.01% | 4509 |
|
|
2022
Q2 | $89K | Hold |
27,600
| – | – | ﹤0.01% | 4569 |
|
|
2022
Q1 | $140K | Buy |
27,600
+1,000
| +4% | +$5.07K | ﹤0.01% | 4518 |
|
|
2021
Q4 | $208K | Hold |
26,600
| – | – | ﹤0.01% | 4332 |
|
|
2021
Q3 | $288K | Buy |
+26,600
| New | +$288K | ﹤0.01% | 4217 |
|